INAB - IN8bio Inc
1.53
-0.030 -1.961%
Share volume: 52,977
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$1.56
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-13-2025 | 05-07-2025 | 11-06-2025 | 03-12-2026 | |
| Assets | ||||||||
| Total Assets | 0.000 | 22.496 M | 15.966 M | 20.944 M | 19.869 M | 16.768 M | 32.282 M | |
| Current Assets | 0.000 | 12.682 M | 6.703 M | 12.578 M | 12.725 M | 11.768 M | 27.880 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 13.015 M | 10.217 M | 4.001 M | 11.120 M | 11.888 M | 10.689 M | 27.092 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.325 M | 3.112 M | 3.081 M | 2.858 M | 2.602 M | 2.103 M | 1.858 M | |
| Other Assets | 256.000 K | 6.702 M | 6.182 M | 5.508 M | 4.542 M | 2.897 M | 2.544 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 0.000 | 22.496 M | 15.966 M | 20.944 M | 19.869 M | 16.768 M | 32.282 M | |
| Total liabilities | 0.000 | 8.875 M | 7.378 M | 6.466 M | 5.992 M | 3.579 M | 4.724 M | |
| Total current liabilities | 0.000 | 4.759 M | 3.635 M | 3.083 M | 2.957 M | 1.703 M | 3.161 M | |
| Accounts Payable | 0.000 | 1.444 M | 1.137 M | 389.000 K | 575.000 K | 204.000 K | 309.000 K | |
| Other liabilities | 4.179 M | 4.116 M | 3.743 M | 3.383 M | 3.035 M | 1.876 M | 1.563 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 4.179 M | 4.116 M | 3.743 M | 3.383 M | 3.035 M | 1.876 M | 1.563 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 0.000 | 13.621 M | 8.588 M | 14.478 M | 13.877 M | 13.189 M | 27.558 M | |
| Common stock | 0.000 | 122.031 M | 124.084 M | 136.134 M | 141.083 M | 149.343 M | 168.654 M | |
| Retained earnings | 0.000 | -108.410 M | -115.496 M | -121.656 M | -127.206 M | -136.154 M | -141.096 M |